SCHEMBL4255118

SCHEMBL4255118

Nc1ncc(C(O)C(=O)O)s1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM8 O00222 1/20 0.51
GRM4 Q14833 1/20 0.51
CSNK2A1 P68400 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.39
NOS1 P29475 1/20 0.38
ALDH1A1 P00352 2/20 0.36
HPGD P15428 1/20 0.36
ALOX15 P16050 1/20 0.36
ADORA3 P0DMS8 1/20 0.35
SLC6A3 Q01959 1/20 0.35
TSHR P16473 1/20 0.34
LMNA P02545 2/20 0.33
MAPK1 P28482 1/20 0.33
POLB P06746 1/20 0.33
PKM P14618 1/20 0.33
PTPN1 P18031 1/20 0.33
PTPN7 P35236 1/20 0.33
BLM P54132 1/20 0.33
KMT2A Q03164 1/20 0.33
ESR2 Q92731 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Water SCHEMBL11005843 0.98 GRM8 (0.50) GRM8GRM4CSNK2A1SMN1; SMN2NOS1
SCHEMBL10074962 0.81 GRM8 (0.51) GRM8GRM4CSNK2A1SMN1; SMN2NOS1
SCHEMBL13095825 0.81 GRM8 (0.51) GRM8GRM4CSNK2A1SMN1; SMN2NOS1
SCHEMBL5029681 0.79 GRM8 (0.47) GRM8GRM4CSNK2A1SMN1; SMN2NOS1
SCHEMBL11037988 0.76 SMN1; SMN2 (0.54) GRM8GRM4CSNK2A1SMN1; SMN2NOS1
SCHEMBL5875737 0.74
SCHEMBL5875700 0.69 GRM8 (0.38) GRM8GRM4CSNK2A1NOS1ALDH1A1
SCHEMBL2896671 0.68
SCHEMBL5023786 0.68 NPC1 (0.41) SMN1; SMN2BLMKMT2AMAPTGAA
SCHEMBL34467428 0.67 CSNK2A1 (0.57) GRM8GRM4CSNK2A1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-59164785-A None JP disclosed
US-20090281142-A1 THIAZOLE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2009-11-12 US disclosed
EP-1921074-A1 THIAZOLE DERIVATIVE Astellas Pharma Inc. (JP) 2008-05-14 EP disclosed
EP-0574118-A1 Polycyclic dyes ZENECA LIMITED (GB) 1993-12-15 EP disclosed
US-4560765-A USING 183-THIAZOL-4-YL GLYOXYLIC ACID AS INTERMEDIATE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-12-24 US disclosed
JP-S59164785-A 2-(2-AMINO-5-THIAZOLYL)-HYDROXYACETIC ACID ESTER AND ITS PREPARATION NIPPON SYNTHETIC CHEM IND CO LTD:THE 1984-09-17 JP disclosed
US-4440766-A CEPHALOSPORINS; BACTERICIDES; MICROBIOCIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-04-03 US disclosed
US-4303655-A MICROBIOCIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090281142-A1 THIAZOLE DERIVATIVE GK, GCKR, AK2 GRM8 565/4885GRM4 502/4885CSNK2A1 1582/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.